Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a WT1-targeted immunotherapy in HLA-A*0201+ WT1+ recurrent/metastatic cancers has completed, including colorectal cancer, gastric cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Cue Biopharma WT1-targeted immunotherapy

Snippet

Sponsor: Cue Biopharma | Conditions: Colorectal Cancer, Gastric Cancer | Phase 1 | Status: COMPLETED